CCCC
C4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
CCCC fundamentals
C4 Therapeutics (CCCC) released its earnings on Aug 7, 2025: revenue was 6.46M (YoY -46.17%), missed estimates; EPS was -0.37 (YoY -42.31%), beat estimates.
Revenue / YoY
6.46M
-46.17%
EPS / YoY
-0.37
-42.31%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Actual | -0.41 | -0.26 | -0.35 | -0.49 | -0.37 | -0.37 | |||||||||||||
Forecast | -0.3649 | -0.3644 | -0.379 | -0.4931 | -0.442 | -0.384 | |||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -12.36% | +28.65% | +7.65% | +0.63% | +16.29% | +3.65% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.04M | 12.01M | 15.40M | 5.18M | 7.20M | 6.46M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 11.99M | 4.78M | 5.90M | 5.09M | 4.45M | 6.55M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -74.66% | +151.00% | +160.97% | +1.66% | +61.80% | -1.33% |
Earnings Call
You can ask Aime
What were the key takeaways from C4 Therapeutics’s earnings call?What were the key takeaways from C4 Therapeutics's earnings call?Did C4 Therapeutics beat or miss consensus estimates last quarter?What does C4 Therapeutics do and what are its main business segments?What factors drove the changes in C4 Therapeutics's revenue and profit?What is the revenue and EPS growth rate for C4 Therapeutics year over year?What guidance did C4 Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for C4 Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
